Anthraquinone anticancer drugs
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 15, 2002
Grant Date -
N/A
app pub date -
Nov 7, 2001
filing date -
Dec 24, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A molecule of formula (I); ##STR1## wherein: X is a halogen, or a substituted sulfonate group; m=1-5; n=1-5; R.sub.1, R.sub.2 =H, C1-4 lower alkyl or C1-4 lower alkyl chain having additional functionality; and the amino group -NR.sub.1 R.sub.2 linked to the anthraquinone is primary, secondary or tertiary or is a tertiary group in the N-oxide form having the formula --N(O)R.sub.1 R.sub.2.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully